Antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infections in a Saudi Arabian hospital

Chemotherapy

Volumn 55, Issue 2, 2009, Pages 127-131

  Al Tawfiq, Jaffar A ^a   Anani, Adnan A ^a  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

Author keywords

Antimicrobial resistance; Enterococcus faecalis; Escherichia coli; Klebsiella pneumoniae; Saudi Arabia; Urinary tract infection

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PENICILLIN G; SULTAMICILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM; BACTERIUM CULTURE; BACTERIUM ISOLATE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SAUDI ARABIA; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS;

EID: 59049092025     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000198698     Document Type: Article

References (20)

1. Stamm WE, Hooton TM: Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-1334.
2. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-758.
3. Hooton TM, Stamm WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551-581.
4. Al-Tawfiq JA: Increasing antibiotic resistance among isolates of Escherichia coli recovered from inpatients and outpatients in a Saudi Arabian hospital. Infect Control Hosp Epidemiol 2006;27:748-753.
5. Clinical and Laboratory Standards Institute (CLSI): Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard, ed 7. Wayne, Clinical and Laboratory Standards Institute, 2006, M7-A7.
6. Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Susceptibility Testing;16th Informational Supplement. Wayne, Clinical and Laboratory Standards Institute, 2006, M100-S16.
7. Jones RN, Kugler KC, Pfaller MA, Winokur PL: Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis 1999;35:55-63.
8. Fadel R, Dakdouki GK, Kanafani ZA, Araj GF, Kanj SS: Clinical and microbiological profile of urinary tract infection at a tertiary-care center in Lebanon. Infect Control Hosp Epidemiol 2004;25:82-85.
9. Kader AA, Kumar A, Dass SM: Antimicrobial resistance patterns of Gram-negative bacteria isolated from urine cultures at a general hospital. Saudi J Kidney Dis Transpl 2004;15:135-139.
10. Guneysel O, Onur O, Erdede M, Denizbasi A: Trimethoprim/sulfamethoxazole resistance in urinary tract infections. J Emerg Med 2008, E-pub ahead of print.
11. Gupta K, Hooton TM, Roberts PL, Stamm WE: Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007;167:2207-2212.
12. Le T, Miller L: Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Clin Infect Dis 2001;33:615-621.
13. Nicolle L, Anderson PA, Conly J, Mainprize TC, Meuser J, Nickel JC, Senikas VM, Zhanel GG: Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Physician 2006;52:612-618.
14. Scottish Intercollegiate Guidelines Network: Management of suspected bacterial urinary tract infection in adults. A National Clinical Guideline (SIGN 88). 2006. http://www.sign.ac.uk/pdf/sign88.pdf (accessed April 19, 2008).
15. Tohme A, Karam-Sarkis D, El-Rassi R, Chelala D, Ghayad E: Agents and consequences of nosocomial infections in a Lebanese university hospital: retrospective study over a two-year period. Ann Med Intern (Paris) 2001;152:77-83.
16. Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W: In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens. Chemotherapy 1998;44:77-84.
17. Grude N, Strand L, Mykland H, Nowrouzian FL, Nyhus J, Jenkins A, Kristiansen BE: Fluoroquinolone-resistant uropathogenic Escherichia coli in Norway: evidence of clonal spread. Clin Microbiol Infect 2008;14:498-500.
18. Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J, Spanish Surveillance Group for Urinary Pathogens: Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 2007;20:68-76.
19. Al-Tawfiq JA, Antony A: Antimicrobial resistance of Klebsiella pneumoniae in a Saudi Arabian hospital: results of a 6-year surveillance study, 1998-2003. J Infect Chemother 2007;13:230-234.
20. Ludwig E: Cefixime in the treatment of respiratory and urinary tract infections. Chemotherapy 1998;44(suppl 1):31-34.